期刊文献+

提升中药材品质紧抓中医临床循证——张伯礼院士谈中医药高质量发展的关键 被引量:5

Improving Quality of Chinese Medicinal Materials,Paying Close Attention to Chinese Medicine Clinical Evidence:Academician ZHANG Bo-li’s Talking About the Key to High-Quality Development of Chinese Medicine
原文传递
导出
摘要 以疗效为本,紧抓中医临床循证,以科技为支撑,提升中药材品质,是中医药高质量发展的必由之路。张伯礼院士提出:中医药转向国际是一个循序渐进的过程,需要苦练内功,“一带一路”倡议的推进,为中医药走向国际带来了机遇,我们需突破瓶颈,抓住机遇,为中医药高质量的发展而努力。 It is mandatory for the high-quality development of Chinese medicine(CM)to by taking curative effect as the basis,focusing on CM clinical evidence,supporting by science and technology and improving the quality of CM.Academician ZHANG Bo-li said,the transformation of CM to the international market is a gradual process,and we need to practice our internal skills.the promotion of"the Belt and Road"strategy has brought opportunities for international of CM.We need to break bottlenecks,seize the opportunity and strive for the high-quality development of CM.
作者 贾贝田 刘海朝 王怡杨 边育红 赵舒武 JIA Bei-tian;LIU Hai-zhao;WANG Yi-yang;BIAN Yu-hong;ZHAO Shu-wu(College of Integrative Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin,301617)
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2023年第1期21-23,共3页 Chinese Journal of Integrated Traditional and Western Medicine
基金 中国工程院咨询研究项目(No.2019-XZ-32)。
关键词 中药材品质 中医临床循证 中西医结合 中医药高质量发展 quality of Chinese medicinal materials Chinese medicine clinical evidence integrated traditional Chinese and Western medicine high-quality development of Chinese medicine
  • 相关文献

参考文献9

二级参考文献8

  • 1陈香美,陈以平,李平,陈建,谌贻璞,周柱亮,陈威,赵宗江,危成筠,魏日胞,邓跃毅,李建军,杜婧,周瑾,何亚妮.1016例IgA肾病患者中医证候的多中心流行病学调查及相关因素分析[J].中国中西医结合杂志,2006,26(3):197-201. 被引量:234
  • 2陈香美,陈以平,周柱亮,陈建,魏日胞,邓跃毅,何亚妮,李平,李建军,罗健华.肾乐胶囊治疗IgA肾病肺脾气虚证患者的前瞻性多中心随机对照临床研究[J].中国中西医结合杂志,2006,26(12):1061-1065. 被引量:37
  • 3Li LS,Liu ZH.Epidemiologic data of renal diseases from a single unit in China:analysis based on 13 519 renal biopsies.Kidney Int 2004;66(3):920-923.
  • 4Wu J,Chen X,Xie Y,et al.Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy.Nephrol Dial Transplant.2005;20(4):719-727.
  • 5Barratt J,Feehally J.Treatment of IgA nephropathy.Kidney Int 2006;69(11):1934-1938.
  • 6Appel GB,Waldman M.The IgA nephropathy treatment dilemma.Kidney Int 2006;69(11):1939-1944.
  • 7Barratt J,Feehally J.IgA nephropathy.J Am Soc Nephrol 2005;16(7):2088-2097.
  • 8Li PK,Ho KK,Szeto CC.et al.Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives.Nephrol Dial Transplant 2002;17(1):64-69.

共引文献87

同被引文献213

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部